Research questions queued for autonomous investigation — enriched with Knowledge Graph context
Quadratic funding rewards broad consensus. Formula: match = (Σ √cᵢ)² - Σ cᵢ · API
Why gaps matter: Each gap represents a strategic opportunity. Filling gaps generates new hypotheses, strengthens evidence networks in the knowledge graph, and improves mission portfolio quality. The system autonomously prioritizes gaps by potential impact, existing KG coverage, and mission alignment.
What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data from the Allen Brain Cell Atlas? Identify mechanisms of
What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data from the Allen Brain Cell Atlas? Identify mechanisms of
What cell types are most vulnerable in Alzheimer's Disease based on SEA-AD transcriptomic data from the Allen Brain Cell Atlas? Identify mechanisms of
The core causation versus correlation debate remains unresolved despite being central to therapeutic strategy. The distinction determines whether TFEB
Investigate the therapeutic potential of clearing senescent cells (senolytics) to slow or reverse neurodegeneration. Key questions: 1. Which senesce
All participants identified BBB penetration as a critical bottleneck, but no existing delivery system (AAV, LNPs) achieves sufficient brain distributi
Investigate mechanistic links between early microglial priming states, neuroinflammatory signaling, and downstream neurodegeneration in preclinical an
Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia subtypes (DAM, homeostatic, inflammatory), astrocyte reactivity states,
Investigate prion-like spreading of tau pathology through connected brain regions, focusing on trans-synaptic transfer, extracellular vesicle-mediated
What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data? Use Allen Brain Cell Atlas evidence. Identify mechanism
Analyze circuit-level changes in neurodegeneration using Allen Institute Neural Dynamics data. Focus on: (1) hippocampal circuit disruption, (2) corti
Evaluate the potential of CRISPR/Cas9 and related gene editing technologies for treating neurodegenerative diseases including Alzheimer disease, Parki
What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference
What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference
What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference
While genetic evidence links autophagy dysfunction to neurodegeneration, the debate highlighted uncertainty about causality in sporadic diseases like
Extracellular vesicles (EVs), including exosomes and microvesicles, carry molecular cargo (proteins, miRNAs, lipids) from their cells of origin, inclu
What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference
The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, but whether therapeutic agonism or antagonism of TREM2 is beneficial rem
What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference
The abstract claims Cdk5 activation is the primary cause of AD, contradicting the established multifactorial etiology involving amyloid plaques, tau t
APOE4 differs from APOE3 by C112R causing domain interaction that alters lipid binding and amyloid clearance.
Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% brain penetrance. Engineering improved BBB transcytosis via transferrin receptor, LRP1, or n
The core debate question remains unresolved - whether intrinsic tau conformational strains or local brain microenvironments determine distinct astrocy
The debate highlighted that while SCFAs can cross the blood-brain barrier, the actual brain concentrations reached through probiotic administration re
While the debate proposes ADCY8-cAMP-PKA-CREB pathways, the exact molecular steps connecting ADCY8 activity to spatial memory encoding remain undefine
The debate identified glycolytic shifts and mTOR disruption but couldn't distinguish pathological changes from adaptive responses. The Skeptic noted t
The debate revealed a critical gap: while PINK1/PARKIN deficiency correlates with excitatory neuron vulnerability, enhancing this pathway could trigge
Investigate prion-like spreading of tau pathology through connected brain regions
The stage-dependent strategy assumes sequential drug switching is feasible, but no evidence exists for safe receptor modulation reversal. The skeptic
The debate revealed that microglial senescence markers are poorly defined compared to other cell types, making selective targeting impossible. Without
The debate identified this correlation but the Skeptic highlighted the critical causality gap. Without resolving directionality, therapeutic intervent
The debate highlighted this fundamental causality question that determines therapeutic strategy. The Skeptic noted methylation drift could be protecti
The debate highlighted that mitochondrial transfer could be therapeutic, but raised concerns about whether mitochondria from AD or other neurodegenera
The debate revealed a fundamental gap: whether disease-specific C1q conformational changes or co-localization patterns exist that could enable selecti
The debate highlighted that RNA granules serve essential physiological functions, but it's unclear whether therapeutic dissolution would be neuroprote
The debate outlined peripheral immune involvement but failed to address the precise trafficking mechanisms and molecular signals that enable monocyte
The fundamental premise remains unvalidated despite extensive mechanistic speculation. Independent validation using purified proteins and orthogonal b
The debate highlighted a critical cell-type specificity gap where no evidence exists for selective microglial targeting of circadian pathways. This fu
The debate highlighted that most promising targets (VAMP2, ESCRT, fascin-1) are essential for basic cellular processes, but the specific dosing/timing
The debate identified that TDP-43 undergoes both normal and pathological phase separation, but no clear molecular criteria were established for design
The debate revealed fundamental uncertainty about whether enhancing TYROBP-SYK signaling would be beneficial or harmful, with existing drugs being SYK
How does microglial priming contribute to early Alzheimer's disease pathology? Focus on the mechanisms by which peripheral inflammation, aging, and ge
The debate revealed fundamental uncertainty about whether HSP70/HSP90 systems can distinguish pathological seeds from normal misfolded intermediates.
The debate identified systemic toxicity as a major concern for glucosylceramide synthase inhibitors, but no dose-response data exists for PD patients.
The debate presented conflicting evidence for convergent vs. stimulus-specific chromatin remodeling. The Skeptic noted that different tissues show dis
The debate highlighted IGFBPL1's potential as a microglial master regulator but identified a critical gap in delivery mechanisms. Without resolving BB
Do these mechanistic hypotheses explain layer-specific synaptic vulnerability in Alzheimer's progression? C1QA layer-specific gradient (0.646), TREM2
The clinical trialist identified this as a 'fatal clinical flaw' - no validated biomarkers exist to measure restored compartmentalization in patients.
The debate proposed α7-containing heteromers (α7β2) might be enriched in stellate neurons but provided no evidence. This is critical since previous br
The debate identified this as a critical mechanistic gap - TFEB may increase lysosomal volume without addressing the fundamental GBA enzyme defect. Th
The debate proposed temporal TREM2 modulation but couldn't define when to switch from inhibition to activation phases. This fundamental timing questio
The debate revealed a fundamental gap in understanding whether tau pathology directly disrupts membrane asymmetry or if PS exposure is merely a conseq
Investigate mechanisms of epigenetic reprogramming in aging neurons
The debate identified a critical gap in understanding whether PS exposure is tau-specific or a general stress marker. This distinction is essential fo
APOE4 is the strongest genetic risk factor for late-onset AD. How APOE4 specifically disrupts lipid homeostasis in astrocytes, cholesterol transport,
The debate highlighted a fundamental uncertainty about whether transgenerational migration routes involve learned spatial memories versus hardwired na
The debate was structured around this question but no literature was provided to address it. Identifying these modifications is critical for developin
The core research question was never addressed due to missing literature content. Identifying these specific modifications is critical for developing
This fundamental question underlies all therapeutic hypotheses but lacks experimental evidence. The debate revealed this is a critical knowledge gap t
The debate hinged on whether HSP90 adopts unique conformations when bound to tau versus other clients, but no structural evidence was provided. This f
The debate highlighted that G2019S shows elevated baseline RAB10 phosphorylation, but it's unclear whether this represents true signal amplification d
test
The P2X7 hypothesis relies on TRIM46-mediated actin polymerization in astrocytes, but TRIM46 is established as neuronal-specific for microtubule organ
test debate [TARGET_ARTIFACT type=experiment id=exp-123]
Does APOE4 drive tau propagation [TARGET_ARTIFACT type=hypothesis id=TEST-123]
The debate proposed biphasic TREM2 modulation but couldn't define when to switch from inhibition to activation. The Skeptic noted AD lacks discrete te
Analyze the spectrum of microglial activation states (DAM, homeostatic, inflammatory) and their distinct roles in AD, PD, and ALS. Identify pharmacolo
RNA binding protein dysregulation across ALS FTD AD
Investigate mechanisms of epigenetic reprogramming in aging neurons
The debate revealed fundamental disagreement about whether C1q has spatially distinct functions at synapses versus microglia, or whether outcomes depe
The debate highlighted compelling correlative evidence for ferroptosis markers in ALS tissues, but causality remains unestablished. This fundamental q
Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576),
Investigate mechanisms of epigenetic reprogramming in aging neurons, including DNA methylation changes, histone modification dynamics, chromatin remod
Investigate mechanisms of epigenetic reprogramming in aging neurons [TARGET_ARTIFACT type=analysis id=SDA-2026-04-04-gap-epigenetic-reprog-b685190e]
Investigate mechanisms of epigenetic reprogramming in aging neurons, including DNA methylation changes, histone modification dynamics, chromatin remod
The debate highlighted focused ultrasound as most feasible but didn't resolve critical dosing parameters. The temporal window for BBB opening and prec
How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synuclein aggregation and dopaminergic neuron survival via vagal nerve signal
Why do entorhinal cortex layer II stellate neurons die first in AD? Their unique electrophysiological properties, grid cell function, and high metabol
Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationship between sleep disorders (particularly circadian
The theorist proposed APOE4 lipidation status affects SREBP2 processing, but the skeptic identified a critical mechanistic gap - no established pathwa
What are the mechanisms by which tau pathology spreads through connected brain regions via prion-like transmission, trans-synaptic transfer, and extra
The debate highlighted TFEB's role in mitochondrial-lysosomal coupling but couldn't resolve causation vs correlation. This distinction is critical for
The debate assumed that correcting APOE4's aberrant domain interactions would restore function, but this wasn't validated. The Skeptic noted that stru
Do these mechanistic hypotheses from the SEA-AD Atlas bundle explain layer-specific synaptic vulnerability in Alzheimer's progression? C1QA layer-spec
The debate highlighted that most SCFA studies use pharmacological doses (mM) rather than physiologically achievable concentrations. This dose-response
The debate highlighted BBB penetration as a major hurdle for SPM therapeutics but provided no mechanistic understanding of transport barriers. This kn
The debate highlighted a critical dosing paradox where both hypo- and hypermethylation could be harmful, but no clear boundaries were established. Thi
The debate highlighted that speech timing and sleep changes could reflect circadian dysfunction, but causality remains unresolved. Determining whether
The debate revealed conflicting evidence about whether connexin-43 mediates mitochondrial transfer through gap junctions or tunneling nanotubes. This
The debate identified a critical mechanistic gap between SCFA production by gut bacteria and α-synuclein disaggregation. While SCFAs cross the blood-b
The debate highlighted major uncertainty about whether rodent glymphatic findings translate to humans, with conflicting evidence on circadian patterns
The debate revealed conflicting evidence about whether HCN1 downregulation drives neuronal death or represents a protective response to excessive exci
The debate identified this as the core knowledge gap but provided no mechanistic insights. Understanding these selectivity rules is essential for pred
The debate revealed that DNAJB6 evidence is limited to polyglutamine aggregation, with no direct testing of heterologous cross-seeding inhibition. Thi
The debate showed compelling in vitro and C. elegans evidence for cross-seeding, but the skeptic raised critical concerns about blood-brain barrier pe
The debate revealed that stress granules can be both neuroprotective and pathological, but the molecular switches governing this transition remain unk
Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationship between sleep disorders (particularly circadian
The debate revealed conflicting estimates ranging from <5% to 20% for FcRn's role in BBB transport, with species differences unresolved. This fundamen
The debate raised this fundamental question but provided no resolution. The Skeptic suggested methylation changes might be protective rather than path
The debate revealed conflicting evidence about C1q's role - some studies show it drives synaptic loss while others suggest it facilitates protective a
The debate proposed bioenergetic gradients drive transfer but didn't identify the specific molecular sensors or trafficking machinery that determines
The debate revealed that no high-resolution structure exists for the critical hinge region (residues 130-160) that allegedly mediates APOE4's patholog
The theorist proposed this novel approach to enable safe agonism across disease stages, but no evidence exists for such selective pathway activation.
The debate highlighted the bidirectional relationship between sleep and neurodegeneration but failed to establish which occurs first in disease progre
The debate highlighted receptor desensitization as a critical concern for SPM receptor priming therapy, but no definitive data exists on whether ALX/F
The debate transcript shows incomplete information exchange, suggesting this fundamental question about microglial phenotyping remains unresolved. Wit
The debate was structured to identify aging-neurodegeneration mechanisms using Allen Brain Atlas data cross-referenced with human AD datasets, but no
The debate failed to produce any actual hypotheses despite this being the core research question. The methodological approach for integrating mouse ag
The debate initiated investigation into white matter aging and myelin changes but was incomplete. The critical gap remains in identifying which molecu
The debate was initiated to analyze cell-type-specific vulnerability using SEA-AD data and Allen Brain Cell Atlas evidence, but no actual analysis or
The debate aimed to cross-reference Allen Aging Mouse Brain Atlas data with human AD datasets but never produced the actual comparative analysis. This
The debate transcript shows incomplete analysis where the Theorist reached maximum tool rounds before presenting hypotheses, and subsequent participan
The debate highlighted that TREM2 therapeutic targeting remains contested across disease stages, but no clear framework exists for when to activate ve
The debate highlighted that long-term CRISPR expression triggers immune responses, but epigenetic therapies require persistence. No clear solution exi
The debate proposed P16INK4A-guided targeting but the Skeptic noted microglia exist in complex activation states that don't fit binary classifications
The debate proposed K280 acetylation creates a β-sheet nucleation interface but lacks structural evidence. Without atomic-level understanding of how a
The debate revealed conflicting therapeutic approaches - enhancing DNA repair versus using PARP inhibitors. The mechanistic direction remains unresolv
The debate highlighted fundamental disagreement about tau's role - whether aggregation causes neuronal death or represents a compensatory mechanism. T
The debate highlighted P2RX7's dual role in both harmful exosome secretion and beneficial microglial responses. The critical therapeutic window betwee
The debate raised conflicting views on whether myelin restoration would be beneficial or harmful in AD. The skeptic suggested myelin loss could be ada
The debate framework identified functional hyperconnectivity as potentially representing either compensatory responses or early pathological changes,
The debate highlighted major safety concerns about blocking CXCL10, particularly increased infection susceptibility, but no long-term studies exist. T
The debate proposed temporal TFEB modulation but identified no validated biomarkers to guide when TFEB should be enhanced versus inhibited. This repre
Multiple participants noted the conflation of cellular dysfunction with senescence, but specific biomarkers to differentiate senescent from reactive a
The debate identified that ketone levels >2.0 mM may disrupt astrocyte-neuron metabolic coupling, but the precise dose-response relationship remains u
The debate generated therapeutic hypotheses targeting different cell types but never resolved the fundamental question of which populations show the s
The debate highlighted promising PTMs like K280 acetylation and O-GlcNAcylation but didn't resolve which modifications can be selectively targeted wit
The ASO therapeutic hypothesis assumes dilncRNAs have targetable conserved structures, but the skeptic noted this is unproven. Without structural char
The debate revealed a critical gap: while excitatory neurons show mitochondrial dysfunction signatures, it's unknown whether enhancing PINK1/PARKIN ac
Investigate the role of neuroinflammation and microglial priming in the earliest stages of Alzheimer's Disease pathology, before clinical symptoms eme
All participants agreed that transcriptomic vulnerability signatures don't establish causation. Distinguishing primary vulnerability mechanisms from d
epigenetic reprogramming aging neurons
The study demonstrates significant reduction in dementia risk (HR 0.63) with GLP-1RA treatment, but the underlying neuroprotective mechanisms remain u
The abstract describes a counterintuitive finding where loss-of-function P/Q mutations that impair transmitter release somehow increase rather than de
The study shows that OB microglia phagocytose LC axons before amyloid plaque formation, but the molecular signals that mark these axons for destructio
The finding that Mertk/Axl deficiency increases viral susceptibility contradicts the established paradigm that TAM receptors dampen antiviral immunity
The abstract describes a novel mechanism where PIKFYVE inhibition triggers exocytosis of aggregation-prone proteins, but the molecular pathway is not
The study shows dramatic functional recovery and muscle re-innervation after cytoplasmic TDP-43 clearance, even following motor neuron death. The cell
The abstract shows that acute neuroinflammation becomes persistent with a specific transcriptomic signature, but the mechanistic drivers of this trans
Despite FDA warnings and a 315% increased erythrocytosis risk with TRT, the association between elevated hematocrit and actual VTE events remains inco
The study demonstrates that exercise-conditioned plasma transfers cognitive benefits, but the identity of the active circulating factors remains unkno
The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation, but the specific molecular interactions and structural changes driving
The abstract explicitly states the critical need to identify genetic risk factors for CTE, but these remain unknown. Understanding genetic susceptibil
The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mice, yet ABCA7 loss-of-function mutations increase LOAD risk. This appa
The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity
This study shows APOE4 carriers have enhanced beneficial innate immune responses, directly contradicting the established view of APOE4 as purely detri
The abstract shows that damaged mitochondrial inner membranes appear early in PLA2G6 KO mice, but the specific biochemical pathways linking phospholip
The abstract reports that pericyte senescence contributes to glioma growth and invasion, but the specific molecular mechanisms linking senescent peric
The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. U
The abstract reveals an unexpected contradiction where PRKN activation, normally considered neuroprotective through damaged mitochondria removal, actu
The study demonstrates that apoE is absolutely required for CAA development, as apoE knockout completely prevents CAA formation. However, the specific
The study demonstrates that SGMS1 elevation correlates with increased Aβ and that SGMS inhibition reduces Aβ production, but the specific biochemical
This study reveals SYNGAP1 expression and function in radial glia before synaptogenesis, contradicting its classification as purely a synaptic protein
The study shows PSEN2 is essential in cortical and dopaminergic neurons and regulates αS expression, but the molecular mechanism linking PSEN2 to synu
The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn't explain how poly(PR) specifically activates p53. Under
The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfun
The abstract shows that IDH mutations reduce protein enzymatic activity yet paradoxically correlate with improved prognosis. This counterintuitive fin
The study identifies KCNJ2 as a therapeutic target through CRISPR screening but doesn't explain the mechanistic pathway by which this mechanosensory c
The study shows SPP1 from perivascular cells drives microglial synaptic engulfment, but the specific receptors, signaling pathways, and molecular casc
The abstract reveals FUS has a chaperone-like function regulating TAZ condensate dynamics, but doesn't address how FUS mutations in ALS/FTD might disr
The abstract identifies APOE4's primary effect on oligodendrocyte cholesterol metabolism but doesn't explain the mechanistic pathway. Understanding th
The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and
Both compounds similarly reduced aging hallmarks (AMPK, Nrf2, COX IV1) and inflammation, yet only Nano-PSO delayed disease progression. This discordan
The abstract reveals contradictory evidence where clusterin is proposed as a protective chaperone protein, yet knockout studies show it exacerbates ne
The study shows deferiprone rescues wild-type cells but exacerbates toxicity in H63D HFE cells, contradicting the assumption that iron reduction is un
PGC-1α is known to enhance mitochondrial function and antioxidant responses, yet overexpression increased susceptibility to MPTP-induced neuronal deat
The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk.
The abstract identifies BACE1 as an attractive drug target but doesn't address its normal physiological roles. Understanding these functions is critic
The abstract claims C. butyricum-GLP-1 crosses the BBB and binds to GLP-1 receptors, but this is mechanistically implausible for a bacterial organism.
The abstract describes astrocyte phenotypic heterogeneity (A1/A2) but doesn't explain the mechanistic switches governing this critical fate decision.
The authors evaluate several ALS-associated mutations in OPTN's leucine-zipper domain but don't fully explain how these mutations mechanistically lead
The authors explicitly state that the effects of these novel genes (MATR3, CHCHD10, TBK1, TUBA4A, NEK1, C21orf2, and CCNF) have not yet been investiga
This finding contradicts the established paradigm that autophagy is generally protective in neurons and neurodegenerative diseases. The counterintuiti
While the study shows HDAC1/2 deletion improves amyloid clearance and cognition, the specific epigenetic and transcriptional changes that enhance phag
The study demonstrates that high-neural glioblastoma cells form synapses with neurons both in vitro and in vivo, but the underlying molecular mechanis
The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synaptic deficits, but the underlying molecular pathways are not explained.
This study identifies oligodendrocytes as drivers of neuroinflammation in PD, contradicting the established paradigm that microglia are the primary ne
The abstract reports extraordinary dopamine increases (>500-fold in drug-free patients) but provides no mechanistic explanation for how Atremorine ach
The observation that salsalate and diflunisal decrease both AD and TBI incidence suggests these drugs may prevent injury occurrence, not just treat co
The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protection, but the mechanistic basis f
Microglia activate astrocytes via IL-1alpha/TNF/C1q, and reactive astrocytes feed back to microglia via complement/chemokines.
The debate focused on therapeutic targets but did not address how to identify patients in the optimal treatment window. Without reliable biomarkers fo
While the study demonstrates dose-response relationships between amyloid levels and outcomes, it doesn't establish specific threshold values for clini
While ACSL4-driven ferroptosis was strongly supported, the molecular triggers that tip the balance from protective GPX4 activity to pathological ACSL4
The debate established that ceramide accumulation affects amyloid-β processing but didn't resolve the spatial specificity of this mechanism. Understan
Synaptic pruning by microglia in early AD
All participants identified brain delivery as a critical barrier, but no mechanism was proposed for overcoming BBB limitations or avoiding systemic cl
GBA mutations impair lysosomal function and promote alpha-synuclein aggregation, but alpha-synuclein itself inhibits GBA activity. The therapeutic imp
While the study establishes LRRK2 as a lysosomal swelling sensor and notes that lysosomal swelling occurs in LRRK2-linked diseases, it doesn't directl
There's a clear disconnect between improved mechanistic understanding of AD and therapeutic success, with continued phase 3 trial failures. This trans
The debate revealed conflicting evidence about whether TRPML1 activation rescues or worsens lysosomal function, with studies showing both therapeutic
Tau pathology spreads through synaptically connected brain regions in Alzheimer disease following a stereotyped anatomical pattern. Mechanisms of tran
The skeptic raised evidence that APOE4 carriers show enhanced cholesterol synthesis, suggesting the lipid binding deficit may be compensatory rather t
The debate identified a critical therapeutic window when astrocytic ketone production declines but neurons retain oxidation capacity, but the exact ti
The debate framework identified synaptic vesicle protein modifications as critical but no specific hypotheses were evaluated. Understanding which phos
The abstract suggests that Aβ-tau synergy could explain negative results from anti-Aβ trials, contradicting the expectation that targeting the presume
While TREM2 was identified as critical for microglial senescence, the debate lacked fine-grained temporal data on when and how TREM2 signaling shifts
The debate revealed contradictory evidence about CD8+ T cell roles in neurodegeneration, with some studies showing protection and others showing harm.
The debate assumed static 5-hydroxymethylcytosine patterns in aging neurons are harmful, but the skeptic raised the possibility these could be stabili